Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$27.47
+1.55%
Mkt Cap $420.97M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | — | — | — | -$1.24 | -$1.12 | +9.59% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.26 | -$0.99 | +21.43% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$1.15 | -$1.05 | +8.70% | — | — |
| Q2 2025 May 9, 2025 | — | — | — | -$1.05 | -$1.08 | -2.86% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$1.04 | -$0.99 | +4.81% | — | — |
| Q4 2024 Nov 18, 2024 | — | — | — | -$1.22 | -$1.19 | +2.46% | — | — |
| Q3 2024 Aug 9, 2024 | — | $925.00K | — | -$1.02 | -$1.09 | -6.86% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$1.03 | -$1.00 | +2.91% | — | — |
| Q1 2024 Mar 26, 2024 | — | — | — | -$1.17 | -$1.51 | -29.06% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.80 | -$0.41 | +48.75% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.15 | -$0.04 | +73.33% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$4.40 | -$0.26 | +94.18% | — | — |
| Q4 2022 Dec 30, 2022 | — | — | — | -$3.80 | -$0.32 | +91.70% | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | -$6.09 | -$2.36 | +61.16% | — | — |
| Q2 2022 Jun 29, 2022 | — | — | — | -$6.00 | -$0.28 | +95.26% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.28 | — | — | — |
| Q4 2021 Dec 30, 2021 | — | — | — | -$5.96 | -$0.36 | +94.01% | — | — |
| Q3 2021 Sep 29, 2021 | — | — | — | — | -$0.28 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | — | — | — | -$0.27 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.27 | — | — | — |